Evidence map›Paper›PMID 37834216›Full record

ArticleInternational journal of molecular sciences2023

Identification of Genomic Regions Implicated in Susceptibility to

Juan Hernández-Goenaga, Julio López-Abán, Adrián Blanco-Gómez, Belén Vicente, Francisco Javier Burguillo, Jesús Pérez-Losada, Antonio Muro

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Juan Hernández-GoenagaGrupo de Enfermedades Infecciosas y Tropicales (e-INTRO), IBSAL-CIETUS (Instituto de Investigación Biomédica de Salamanca, Centro de Investigación de Enfermedades Tropica-les de la Universidad de Salamanca), Facultad de Farmacia, Universidad de Salamanca, Ldo. Méndez Nieto s/n, 37007 Salamanca, Spain.
Julio López-AbánGrupo de Enfermedades Infecciosas y Tropicales (e-INTRO), IBSAL-CIETUS (Instituto de Investigación Biomédica de Salamanca, Centro de Investigación de Enfermedades Tropica-les de la Universidad de Salamanca), Facultad de Farmacia, Universidad de Salamanca, Ldo. Méndez Nieto s/n, 37007 Salamanca, Spain.
Adrián Blanco-GómezInstituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Hospital Virgen de la Vega, 37007 Salamanca, Spain.
Belén VicenteGrupo de Enfermedades Infecciosas y Tropicales (e-INTRO), IBSAL-CIETUS (Instituto de Investigación Biomédica de Salamanca, Centro de Investigación de Enfermedades Tropica-les de la Universidad de Salamanca), Facultad de Farmacia, Universidad de Salamanca, Ldo. Méndez Nieto s/n, 37007 Salamanca, Spain.
Francisco Javier BurguilloDepartamento de Química-Física, Facultad de Farmacia, Universidad de Salamanca, C/Donantes de Sangre s/n. Campus Unamuno, 37007 Salamanca, Spain.
Jesús Pérez-LosadaInstituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Hospital Virgen de la Vega, 37007 Salamanca, Spain.ORCID 0000-0003-2400-624X
Antonio MuroGrupo de Enfermedades Infecciosas y Tropicales (e-INTRO), IBSAL-CIETUS (Instituto de Investigación Biomédica de Salamanca, Centro de Investigación de Enfermedades Tropica-les de la Universidad de Salamanca), Facultad de Farmacia, Universidad de Salamanca, Ldo. Méndez Nieto s/n, 37007 Salamanca, Spain.ORCID 0000-0003-0244-4740
Universidad de Salamanca · ESComplejo Hospitalario de Salamanca · ES

Funding

Institute of Health Carlos III, ISCIII, Spain PI22/01721Institute of Health Carlos III, ISCIII, Spain RICET RD16/0027/0018MCIN/AEI/ doi 10.13039/501100011033 cofounded by the European Union PID2021-127471OB-I00MCIN/AEI/ doi 10.13039/501100011033 cofounded by the European Union PID2022-136462NB-I00
6 · The paper itself

Abstract

Only a small number of infected people are highly susceptible to schistosomiasis, showing high levels of infection or severe liver fibrosis. The susceptibility to schistosome infection is influenced by genetic background. To assess the genetic basis of susceptibility and identify the chromosomal regions involved, a backcross strategy was employed to generate high variation in schistosomiasis susceptibility. This strategy involved crossing the resistant C57BL/6J mouse strain with the susceptible CBA/2J strain. The resulting F1 females (C57BL/6J × CBA/2J) were then backcrossed with CBA/2J males to generate the backcross (BX) cohort. The BX mice exhibited a range of phenotypes, with disease severity varying from mild to severe disease, lacking a fully resistant group. We observed four levels of infection intensity using cluster and principal component analyses and K-means based on parasitological, pathological, and immunological trait measurements. The mice were genotyped with 961 informative SNPs, leading to the identification of 19 new quantitative trait loci (QTL) associated with parasite burden, liver lesions, white blood cell populations, and antibody responses. Two QTLs located on chromosomes 15 and 18 were linked to the number of granulomas, liver lesions, and IgM levels. The corresponding syntenic human regions are located in chromosomes 8 and 18. None of the significant QTLs had been reported previously.

Indexed as

Liver NeoplasmsSchistosomiasisSchistosomiasis mansoniAnimalsDisease SusceptibilityFemaleGenomicsHumansMaleMiceMice, Inbred C57BLMice, Inbred CBAModels, GeneticSchistosoma mansonibackcross schistosomiasisgenetic susceptibilitygenomic regionpathologySchistosoma mansonischistosomiasis

Identifiers

PMID37834216
PMCPMC10573152
OpenAlexW4387230652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.